Sanofi (NASDAQ:SNY) is initiating a voluntary recall of some lots of its Typhim Vi vaccine,...

Sanofi (NASDAQ:SNY) is initiating a voluntary recall of some lots of its Typhim Vi vaccine, saying they may be at risk for lower antigen content. The FDA notes, "There is no safety concern related to this action."